These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38077942)

  • 1. Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Sobhan Bahreiny S; Ahangarpour A; Asghar Hemmati A; Kazemzadeh R; Bastani MN; Reza Dabbagh M; Aghaei M
    Int J Reprod Biomed; 2023 Oct; 21(10):777-788. PubMed ID: 38077942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating serum preptin levels in women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Sobhan Bahreiny S; Harooni E; Reza Dabbagh M; Ebrahimi R
    Int J Reprod Biomed; 2023 May; 21(5):367-378. PubMed ID: 37362092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Galectin-3 levels in women with polycystic ovary syndrome: A meta-analysis.
    Bahreiny SS; Bastani MN; Aghaei M; Dabbagh MR; Mahdizade AH
    Taiwan J Obstet Gynecol; 2024 Jan; 63(1):37-45. PubMed ID: 38216266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleobindin-2 derived nesfatin-1 in polycystic ovary syndrome: a PRISMA and GRADE-compliant systematic review and meta-analysis with diagnostic test accuracy.
    Venkata Nagaraju K; Lisa M; Varikasuvu SR; Kumar S; Singh H; Pérez-López FR; Gupta P; Varshney S
    Minerva Endocrinol (Torino); 2024 Mar; 49(1):111-121. PubMed ID: 37943280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood nesfatin-1 levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
    Wang M; Tong J; Zhu Q; Tang H; Tang L
    Front Endocrinol (Lausanne); 2023; 14():1275753. PubMed ID: 38327900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating kisspeptin and anti-müllerian hormone levels, and insulin resistance in women with polycystic ovary syndrome: A systematic review, meta-analysis, and meta-regression.
    Pérez-López FR; Ornat L; López-Baena MT; Santabárbara J; Savirón-Cornudella R; Pérez-Roncero GR
    Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():85-98. PubMed ID: 33744505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean platelet volume and polycystic ovary syndrome: a systematic review and meta-analysis.
    Li L; Yu J; Zhou Z
    J Int Med Res; 2022 Jan; 50(1):3000605211067316. PubMed ID: 34986678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and follicular fluid chemerin and chemerin mRNA expression in women with polycystic ovary syndrome: Systematic review and meta-analysis.
    Mansoori A; Amoochi-Foroushani G; Zilaee M; Hosseini SA; Azhdari M
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00307. PubMed ID: 34699139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging-Based Body Fat Distribution in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
    Zhu S; Li Z; Hu C; Sun F; Wang C; Yuan H; Li Y
    Front Endocrinol (Lausanne); 2021; 12():697223. PubMed ID: 34566888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asprosin levels in women with and without the polycystic ovary syndrome: a systematic review and meta-analysis.
    Pérez-López FR; López-Baena MT; Pérez-Roncero GR; Chedraui P; Varikasuvu SR; García-Alfaro P
    Gynecol Endocrinol; 2023 Dec; 39(1):2152790. PubMed ID: 36480935
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune thyroid disorders and polycystic ovary syndrome: Tracing links through systematic review and meta-analysis.
    Bahreiny SS; Ahangarpour A; Amraei M; Mansouri Z; Pirsadeghi A; Kazemzadeh R; Javidan M; Karamali N; Bastani MN; Dabbagh MR
    J Reprod Immunol; 2024 Jun; 163():104215. PubMed ID: 38402811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating chemerin levels in women with polycystic ovary syndrome: a meta-analysis.
    Wang X; Zhang Q; Zhang L; Wei W; Liu L; Li B; Zhang L; Zhang Y; Hui Y; Lei Y
    Gynecol Endocrinol; 2022 Jan; 38(1):22-27. PubMed ID: 34402730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis.
    Tang YL; Yu J; Zeng ZG; Liu Y; Liu JY; Xu JX
    Gynecol Endocrinol; 2017 Mar; 33(3):244-249. PubMed ID: 27908216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
    Cooney LG; Lee I; Sammel MD; Dokras A
    Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between neutrophil-to-lymphocyte ratio and polycystic ovary syndrome: A PRISMA-compliant systematic review and meta-analysis.
    Li L; Yu J; Zhou Z
    Medicine (Baltimore); 2022 Sep; 101(38):e30579. PubMed ID: 36197242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis.
    Wu ZH; Tang Y; Niu X; Pu FF; Xiao XY; Kong W
    J Ovarian Res; 2019 Oct; 12(1):94. PubMed ID: 31615559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis.
    Gao Y; Xin C; Fan H; Sun X; Wang H
    Front Endocrinol (Lausanne); 2022; 13():1076951. PubMed ID: 36714603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study.
    Demir Çaltekin M; Caniklioğlu A; Eris Yalçın S; Aydoğan Kırmızı D; Baser E; Yalvaç ES
    Turk J Obstet Gynecol; 2021 Jun; 18(2):124-130. PubMed ID: 34083652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome.
    Ademoglu EN; Gorar S; Carlıoglu A; Yazıcı H; Dellal FD; Berberoglu Z; Akdeniz D; Uysal S; Karakurt F
    J Endocrinol Invest; 2014 Aug; 37(8):715-719. PubMed ID: 24920281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.